Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory Non–Hodgkin Lymphoma
暂无分享，去创建一个
A. Zelenetz | A. Iasonos | O. O’Connor | J. Gerecitano | Zhigang Zhang | P. Hamlin | C. Moskowitz | A. Noy | C. Portlock | D. Straus | D. Sarasohn | P. Schulman | Celeste Rojas | Otilia Dumitrescu | Jennifer Pappanicholaou | Q. Mo | Endri Horanlli | C. Rojas